Eastman Chemical (EMN) Cash & Equivalents (2009 - 2026)

Eastman Chemical has reported Cash & Equivalents for 18 years, with the latest figure at $691.0 million in Q2 2026.

• Cash & Equivalents for Q2 2026 came in at $691.0 million, up 63.36% year-over-year; the trailing twelve-month figure through Jun 2026 was $691.0 million (up 63.36% YoY), and the FY2025 annual result was $566.0 million, down 32.38% from the prior year.
• Cash & Equivalents climbed to $691.0 million in Q2 2026, from $665.0 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $837.0 million in Q4 2024 and troughed at $410.0 million in Q2 2023.
• A 5-year average of $534.3 million and a median of $496.0 million in 2022 frame the typical range for Cash & Equivalents.
• The widest annual swing landed in 2022, when Cash & Equivalents tumbled 35.7%; it then jumped 63.36% in 2026.
• A 5-year view of Cash & Equivalents shows it stood at $493.0 million in 2022, then advanced by 11.16% to $548.0 million in 2023, then soared by 52.74% to $837.0 million in 2024, then slumped by 32.38% to $566.0 million in 2025, then gained by 22.08% to $691.0 million in 2026.
• Per Business Quant data, the three most recent Cash & Equivalents figures were $691.0 million in Q2 2026, $665.0 million in Q1 2026, and $566.0 million in Q4 2025.